CHEMCRUX

Vadodara, India Founded: 1983 • Age: 43 yrs Listed
Intermediates for bulk drugs, dyes, and pigments are manufactured.

About CHEMCRUX

CHEMCRUX is a publicly listed company based in Vadodara (India) founded in 1983. Intermediates for bulk drugs, dyes, and pigments are manufactured. The company has 102 employees. Its Indian entity Chemcrux Enterprises Limited reported revenue of β‚Ή82.67 Cr. CHEMCRUX offers products and services including Chemical Intermediates, Bulk Drugs (API), Dyes, and Pigments. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

CHEMCRUX was established in 1983 in Vadodara, India, within the chemical manufacturing sector. Intermediates essential for bulk drugs, dyes, and pigments are produced by the company. Operations are centered on supplying these materials to pharmaceutical and pigment industries. The facility supports regional and export demands in the sector. Leadership is held by Managing Director Sanjay Marathe, overseeing production and distribution activities.

  • Headquarters Vadodara, India
  • Employees 102
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website chemcrux.com
  • Legal Name Chemcrux Enterprises Ltd.
Key Metrics
  • Market Cap
    ₹117 Cr

    CHEMCRUX · NSE

  • Share Price
    ₹78.80

    -0.40% today

  • Revenue
    ₹80.65 Cr

    FY 2025-26 · +15.2% YoY

  • EBITDA
    ₹11.14 Cr

    Margin 13.8%

  • Net Profit
    ₹2.28 Cr

    FY 2025-26 · -35.2% YoY

  • P/E (TTM)
    25.8x

    P/B 1.5x

  • ROE
    3.0%

    ROCE 6.4%

  • Debt / Equity
    0.51

    Interest cover 49.1x

  • Employee Count
    102

Products & Services of CHEMCRUX

CHEMCRUX offers a comprehensive portfolio of products and services, including Chemical Intermediates, Bulk Drugs (API), Dyes, and Pigments.

Chemical Intermediates
Manufacturing

Products used in various chemical processes for industrial applications

Bulk Drugs (API)
Pharmaceuticals

Active ingredients for drug manufacturing and health sectors

Dyes
Materials

Coloring agents for textiles and industrial uses

Pigments
Materials

Substances for coloring and coating in manufacturing

Board of directors of Chemcrux Enterprises Limited (CHEMCRUX)

Chemcrux Enterprises Limited is the primary company behind CHEMCRUX. The boards of the 2 registered companies of CHEMCRUX currently have 8 directors; the longest-serving is Sanjay Yashawantrao Marathe, appointed in 1996. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sanjay Yashawantrao Marathe
DIN 01316388
Managing Director15 Apr 199630 yrs 6 moChemcrux Enterprises Limited
Girishkumar Shah
DIN 00469291
Whole-time director01 Jan 201313 yrs 10 moChemcrux Enterprises Limited
Deepak Kumar
DIN 01616201
Managing Director23 Feb 20179 yrs 8 moPushpanjali Realms And Infratech Limited
Rajpal Walia
DIN 06829234
Whole-time director23 Feb 20179 yrs 8 moPushpanjali Realms And Infratech Limited
Nayankumar Champaklal Shah
DIN 10824202
Director21 Dec 20241 yr 10 moChemcrux Enterprises Limited
Vipul Pramodchandra Sanghvi
DIN 10824210
Whole-time director21 Dec 20241 yr 10 moChemcrux Enterprises Limited
Rohit Kothari
DIN 00090408
Director12 Feb 20251 yr 8 moChemcrux Enterprises Limited
Zarna Pankaj Thakar
DIN 11869662
Director04 Aug 20263 moChemcrux Enterprises Limited

People of CHEMCRUX

1 people are tracked at CHEMCRUX (1 in leadership); the tracked headcount is 102.

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for CHEMCRUX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of CHEMCRUX

CHEMCRUX is a publicly listed company on the BSE with ticker symbol CHEMCRUX in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Mar 2017
  • Listed onBSE: 540395
  • Listed entityChemcrux Enterprises Ltd.
  • Exchange sectorProcess industries
  • ISININE298W01016
  • Share price₹93.16 (-0.79% on the day) · 2026-05-11
  • Market capitalisation₹139 Cr
  • Price to earnings66.1
  • EPS (diluted, trailing year)₹1.41
  • Dividend yield1.07%
  • Volume (last session)6,220
  • Analyst consensusNo rating

Financials of CHEMCRUX

Exchange-reported figures of Chemcrux Enterprises Limited, the listed company behind CHEMCRUX (NSE: CHEMCRUX).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹80.65 Cr
+15.2% YoY
EBITDA
₹11.14 Cr
+20.7% YoY
Profit After Tax
₹2.28 Cr
-35.2% YoY
Net Worth
₹76.85 Cr
+3.0% YoY
Total Assets
₹111 Cr
-4.8% YoY
Total Debt
₹34.37 Cr
-18.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue80.6570.0178.4795.1595.27
Revenue growth+15.2%-10.8%-17.5%-0.1%-
EBITDA11.149.2313.2221.4520.71
EBITDA margin+13.8%+13.2%+16.9%+22.5%+21.7%
Profit before tax5.285.7611.4419.6419.95
Net profit2.283.528.3214.0614.67
Net profit margin+2.8%+5.0%+10.6%+14.8%+15.4%
EPS (β‚Ή)2.522.645.709.7010.03
Balance sheet
Total assets11111798.8980.8364.43
Net worth76.8574.6272.2666.4154.68
Total debt34.3742.3026.4614.439.75
Cash & bank2.571.155.187.0911.87
Net working capital18.4520.1621.2527.8829.74
Cash flow
Cash from operations13.857.5916.3414.829.16
Cash from investing(0.07)(5.98)(25.89)(20.48)(2.64)
Cash from financing(12.36)(5.66)7.640.963.96
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.8421.9424.2822.1117.7516.5015.7219.42
Revenue growth (YoY)+34.3%+33.0%+54.5%+13.9%-0.1%-3.6%--
Other income0.070.110.360.600.630.440.240.61
EBITDA2.852.704.193.531.801.622.112.69
EBITDA margin+12.0%+12.3%+17.3%+16.0%+10.1%+9.8%+13.4%+13.9%
Depreciation1.201.181.171.191.201.180.990.92
Interest0.620.640.700.760.830.860.690.60
Profit before tax1.100.992.682.180.400.020.671.78
Tax0.560.480.820.610.18(0.07)0.460.46
Net profit0.540.511.861.570.220.090.211.32
EPS (β‚Ή)0.370.341.251.060.140.060.140.89
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue82.5870.2578.4795.1595.2753.3357.45
Revenue growth+17.6%-10.5%-17.5%-0.1%+78.6%-7.2%-
EBITDA10.259.0613.2221.4520.7112.5614.74
EBITDA margin+12.4%+12.9%+16.9%+22.5%+21.7%+23.6%+25.7%
Profit before tax7.205.8211.4419.6419.9512.0514.17
Net profit4.053.808.3214.0614.678.8010.31
Net profit margin+4.9%+5.4%+10.6%+14.8%+15.4%+16.5%+18.0%
EPS (β‚Ή)3.682.835.709.7010.0318.1021.56
Balance sheet
Total assets10210398.8980.8363.7941.7834.33
Net worth80.0676.1172.2666.4154.6840.8632.42
Total debt22.2126.8126.4614.439.110.931.92
Cash & bank2.561.145.187.0911.802.712.89
Net working capital18.1919.1021.2527.8829.7013.0512.03
Cash flow
Cash from operations12.207.0716.3414.829.149.6210.90
Cash from investing(2.28)(7.93)(25.89)(20.48)(2.64)(8.16)(7.62)
Cash from financing(8.50)(3.18)7.640.962.76(0.76)(3.56)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.8421.9424.2823.0018.5516.7515.9719.42
Revenue growth (YoY)+28.5%+31.0%+52.0%+18.4%+4.5%-2.1%--
Other income0.310.310.530.740.800.610.280.61
Total expenses20.6719.1020.6519.6416.8915.1514.0216.73
EBITDA3.172.843.633.361.661.601.952.69
EBITDA margin+13.3%+12.9%+15.0%+14.6%+8.9%+9.6%+12.2%+13.9%
Depreciation0.960.950.940.950.960.950.910.92
Interest0.340.340.400.460.520.520.580.60
Profit before tax2.181.862.822.690.980.740.741.78
Tax0.560.480.820.610.180.140.260.46

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 06 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.8421.9424.2822.1117.7516.5015.7219.42
Revenue growth (YoY)+34.3%+33.0%+54.5%+13.9%-0.1%-3.6%--
Other income0.070.110.360.600.630.440.240.61
EBITDA2.852.704.193.531.801.622.112.69
EBITDA margin+12.0%+12.3%+17.3%+16.0%+10.1%+9.8%+13.4%+13.9%
Depreciation1.201.181.171.191.201.180.990.92
Interest0.620.640.700.760.830.860.690.60
Profit before tax1.100.992.682.180.400.020.671.78
Tax0.560.480.820.610.18(0.07)0.460.46
Net profit0.540.511.861.570.220.090.211.32
EPS (β‚Ή)0.370.341.251.060.140.060.140.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue80.6570.0178.4795.1595.27
Revenue growth+15.2%-10.8%-17.5%-0.1%-
Other income2.021.491.341.051.00
Total expenses69.5160.7865.2573.7074.56
Employee cost9.638.568.837.916.32
EBITDA11.149.2313.2221.4520.71
EBITDA margin+13.8%+13.2%+16.9%+22.5%+21.7%
Depreciation4.733.212.292.041.59
Interest3.151.750.830.820.17
Profit before tax5.285.7611.4419.6419.95
Tax1.551.852.995.295.09
Net profit2.283.528.3214.0614.67
Net profit margin+2.8%+5.0%+10.6%+14.8%+15.4%
EPS (β‚Ή)2.522.645.709.7010.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital14.8114.8114.8114.8114.81
Reserves & surplus62.0459.8157.4551.6039.87
Shareholders' funds (net worth)76.8574.6272.2666.4154.68
Minority interest0.000.000.000.000.00
Secured loans27.5632.3721.5513.278.00
Unsecured loans6.819.934.911.161.75
Total debt34.3742.3026.4614.439.75
Total liabilities11111798.8980.8364.43
Assets
Gross block95.3292.6945.7243.5834.07
Net block74.9677.0633.0933.1125.49
Capital work in progress4.081.6121.060.310.00
Investments15.9319.8319.8316.797.08
Inventories6.1110.028.4114.0911.57
Sundry debtors18.9111.7815.3013.4418.88
Cash & bank balances2.571.155.187.0911.87
Loans & advances2.863.601.173.845.47
Total current assets30.4526.5530.0638.4647.79
Total current liabilities12.006.398.8110.5818.05
Net working capital18.4520.1621.2527.8829.74
Total assets11111798.8980.8364.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash1.155.187.0911.802.54
Net cash from operating activities13.857.5916.3414.829.16
Net cash from investing activities(0.07)(5.98)(25.89)(20.48)(2.64)
Net cash from financing activities(12.36)(5.66)7.640.963.96
Net change in cash1.42(4.04)(1.91)(4.70)10.49
Closing cash2.571.155.187.0911.87
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+15.2%-10.8%-17.5%-0.1%-
EBITDA growth+20.7%-30.2%-38.4%+3.6%-
PBT growth-8.3%-49.7%-41.8%-1.6%+9997.0%
Net income growth-35.2%-57.7%-40.8%-4.2%-
Revenue CAGR (3Y)-5.4%-9.8%---
EBITDA CAGR (3Y)-19.6%-23.6%---
Profitability & leverage
Net income margin+4.6%+5.6%+10.8%+15.1%+15.6%
Return on capital employed+6.4%+7.0%+13.6%+28.2%+31.2%
Return on net worth+3.0%+5.3%+12.2%+23.7%+27.2%
Debt / equity0.510.470.290.200.18
Long-term debt / equity0.330.350.240.100.02
Interest cover49.1429.077.594.220.89
Efficiency & per share
Fixed asset turnover0.861.011.762.452.80
Inventory turnover10.007.606.987.428.23
Debtors turnover5.265.175.465.895.05
EPS (β‚Ή)2.522.645.709.7010.03
Dividend per share (β‚Ή)1.001.001.002.002.00
Book value per share (β‚Ή)51.9050.3948.7944.8436.93
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.8421.9424.2823.0018.5516.7515.9719.42
Revenue growth (YoY)+28.5%+31.0%+52.0%+18.4%+4.5%-2.1%--
Other income0.310.310.530.740.800.610.280.61
Total expenses20.6719.1020.6519.6416.8915.1514.0216.73
EBITDA3.172.843.633.361.661.601.952.69
EBITDA margin+13.3%+12.9%+15.0%+14.6%+8.9%+9.6%+12.2%+13.9%
Depreciation0.960.950.940.950.960.950.910.92
Interest0.340.340.400.460.520.520.580.60
Profit before tax2.181.862.822.690.980.740.741.78
Tax0.560.480.820.610.180.140.260.46
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue82.5870.2578.4795.1595.2753.3357.45
Revenue growth+17.6%-10.5%-17.5%-0.1%+78.6%-7.2%-
Other income2.671.531.341.051.000.840.93
Total expenses72.3361.1965.2573.7074.5640.7742.71
Employee cost9.088.538.837.916.324.023.70
EBITDA10.259.0613.2221.4520.7112.5614.74
EBITDA margin+12.4%+12.9%+16.9%+22.5%+21.7%+23.6%+25.7%
Depreciation3.813.132.292.041.591.201.18
Interest1.911.640.830.820.170.150.32
Profit before tax7.205.8211.4419.6419.9512.0514.17
Tax1.761.642.995.295.093.113.54
Net profit4.053.808.3214.0614.678.8010.31
Net profit margin+4.9%+5.4%+10.6%+14.8%+15.4%+16.5%+18.0%
EPS (β‚Ή)3.682.835.709.7010.0318.1021.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.8114.8114.8114.8114.814.944.94
Reserves & surplus65.2561.3057.4551.6039.8735.9227.48
Shareholders' funds (net worth)80.0676.1172.2666.4154.6840.8632.42
Secured loans17.0921.4121.5513.278.000.371.82
Unsecured loans5.125.404.911.161.110.560.10
Total debt22.2126.8126.4614.439.110.931.92
Total liabilities10210398.8980.8363.7941.7834.33
Assets
Gross block75.5473.1045.7243.5832.9126.2321.06
Net block56.1857.5533.0933.1124.3319.3715.40
Capital work in progress4.081.6121.060.310.000.320.00
Investments15.9419.8419.8316.797.099.356.53
Inventories6.039.658.4114.0911.577.374.55
Sundry debtors19.2512.2115.3013.4418.883.319.41
Cash & bank balances2.561.145.187.0911.802.712.89
Loans & advances1.551.801.173.845.495.474.40
Total current assets29.3924.8030.0638.4647.7418.8621.25
Total current liabilities11.205.708.8110.5818.045.819.22
Net working capital18.1919.1021.2527.8829.7013.0512.03
Total assets10210398.8980.8363.7941.7834.33
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.145.187.0911.802.540.003.18
Net cash from operating activities12.207.0716.3414.829.149.6210.90
Net cash from investing activities(2.28)(7.93)(25.89)(20.48)(2.64)(8.16)(7.62)
Net cash from financing activities(8.50)(3.18)7.640.962.76(0.76)(3.56)
Net change in cash1.42(4.04)(1.91)(4.70)9.260.69(0.29)
Closing cash2.561.145.187.0911.802.712.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+17.6%-10.5%-17.5%-0.1%+78.6%-7.2%-
EBITDA growth+13.1%-31.5%-38.4%+3.6%+64.9%-14.8%-
PBT growth+23.7%-49.1%-41.8%-1.6%+65.6%-15.0%+14.7%
Net income growth+6.6%-54.3%-40.8%-4.2%+66.7%-14.7%-
Revenue CAGR (3Y)-4.6%-9.7%+13.7%+18.3%+19.9%+19.2%+27.8%
EBITDA CAGR (3Y)-21.8%-24.1%+1.7%+13.3%+15.6%+38.6%+62.7%
Profitability & leverage
Net income margin+6.6%+6.0%+10.8%+15.1%+15.6%+16.8%+18.5%
Return on capital employed+7.8%+7.4%+13.6%+28.3%+38.1%+32.0%+47.4%
Return on net worth+5.2%+5.7%+12.2%+23.7%+31.1%+24.4%+37.8%
Debt / equity0.310.360.290.190.110.040.09
Long-term debt / equity0.210.270.240.100.020.020.05
Interest cover29.6627.667.594.220.891.322.36
Efficiency & per share
Fixed asset turnover1.111.181.762.493.222.263.56
Inventory turnover10.537.786.987.4210.068.9513.27
Debtors turnover5.255.115.465.898.598.395.68
EPS (β‚Ή)3.682.835.709.7010.0318.1021.56
Dividend per share (β‚Ή)1.001.001.002.002.002.004.00
Book value per share (β‚Ή)54.0651.4048.7944.8436.9382.7665.66

Web traffic of CHEMCRUX

The website of CHEMCRUX (chemcrux.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▼ 59.9% vs previous month

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as CHEMCRUX (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Chemcrux

Premium access

Complete news archive for CHEMCRUX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CHEMCRUX

CHEMCRUX was founded in 1983.

CHEMCRUX is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

CHEMCRUX has 102 employees.

The primary company behind CHEMCRUX, Chemcrux Enterprises Limited, reported revenue of β‚Ή82.67 Cr for FY 2026, up 15% year on year.

CHEMCRUX was established in 1983 in Vadodara, India, within the chemical manufacturing sector. Intermediates essential for bulk drugs, dyes, and pigments are produced by the company. Operations are centered on supplying these materials to pharmaceutical and pigment industries. The facility supports regional and export demands in the sector. Leadership is held by Managing Director Sanjay Marathe, overseeing production and distribution activities.

CHEMCRUX offers Chemical Intermediates, Bulk Drugs (API), Dyes, and Pigments.

Yes, CHEMCRUX is publicly traded on BSE under the ticker symbol CHEMCRUX.

CHEMCRUX is associated with 2 legal entities: Chemcrux Enterprises Limited, Pushpanjali Realms And Infratech Limited.

The legal entities of CHEMCRUX currently have 10 directors, including Dipika Kumar Rajpal, Girishkumar Shah, Sanjay Yashawantrao Marathe and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available